Under all Marketplace plans and most private plans, you have access to free preventive services to help you get the treatment you need. Services include:
- Immunizations
- Screenings for depression, tobacco-use, alcohol use, sexually transmitted infection (STI), blood pressure, cholesterol, domestic violence, and more
- Annual Well Visits
- Contraception
- Women’s preventive services (e.g. Pap smear, mammography). This applies regardless of your gender identity or transgender status.
Coverage of Pre-Exposure Prophylaxis Prescription Drugs and Baseline and Monitoring Services
Under the Affordable Care Act (ACA), health insurance companies offering individual and group health insurance plans must provide coverage for specified preventive services, including preventive services that receive a rating of “A” or “B” by the United States Preventive Services Task Force (USPSTF). In June 2019, the USPSTF released a recommendation that pre-exposure prophylaxis (PrEP) be offered to those at higher risk of contracting human immunodeficiency virus (HIV) and/or acquired immunodeficiency syndrome (AIDS). PrEP is a medication which, if taken as prescribed, reduces the risk of getting HIV via sexual contact or among persons who inject drugs. The US Food and Drug Administration (FDA) has currently approved two daily pills, Truvada® and Descovy®, and the injective medication Apretude, for PrEP.
Based on the June 2019 USPSTF recommendation, all insurance companies offering individual and group health insurance plans offering after June 30, 2020, must cover PrEP with no cost sharing - IE, no copayment or coinsurance - to plan members. In July 2021, the United States Departments of Health and Human Services, Labor, and the Treasury issued additional guidance, clarifying that individual and group health insurance plans must also cover services related to PrEP, including office visits associated with baseline and ongoing monitoring; HIV, Hepatitis B and C, and kidney function testing; pregnancy testing; sexually transmistted infection screening and counseling; and adherence counseling.
The Division’s guidance on PrEP coverage is contained in the Division's Regulation 4-2-73 Concerning Human Immunodeficiency Virus Pre-Exposure Prophylaxis Prescription Drugs and Bulletin B-4.112 Policy Directives for Coverage of HIV Prevention Ancillary Services. NOTE: The Division recently updated Regulation 4-2-73 to include coverage or baseline and monitoring services associated with PrEP. The amended regulation, which will be effective on March 2, 2022, is available on the Division's Regulations Adopted But Not Yet Effective webpage.
For additional information about PrEP, please see the following resources: